Related Experiment Video
Updated: May 24, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
[Resveratrol: a neuroprotective polyphenol in the Mediterranean diet]
Visitación López-Miranda1, M Luisa Soto-Montenegro, Gema Vera
1Departamento de Farmacología y Nutrición y Unidad Asociada al Instituto de Química Médica del CSIC, Universidad Rey Juan Carlos, Facultad de Ciencias de la Salud, 28922 Alcorcon, Espana.
Introduction:
Resveratrol is a polyphenol present in grapes, some nuts and dried fruits, and red wine. A number of beneficial properties have been attributed to this compound. Its potential neuroprotective effects are the subject of much research today.
Aim:
To review the effects of resveratrol, and more particularly those related to its capacity to offer protection against the neurodegeneration associated with several pathologies and traumatic injuries in the central nervous system.
Development:
It has been suggested that the daily consumption of red wine, and therefore of resveratrol, could account for the so-called 'French paradox', according to which the population in the south of France, despite eating a diet that is relatively high in saturated fats, presents a low risk of heart disease. From this first evidence of the cardioprotective properties of resveratrol, its study has been extended and equally attractive biopharmacological effects have now been found in many different fields. Thus, neuroprotective effects have been found in models of neurodegeneration (Alzheimer's, Parkinson's or Huntington's disease, or diverse neuropathies), of ischaemia and of brain and spinal cord injury, but further clinical data are still needed in this regard.
Conclusions:
Although few studies have been conducted in humans, recent findings in experimental models of neurological pathology are encouraging and open up the doors to future clinical studies that will allow the therapeutic value of resveratrol to be determined.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmacodynamics in Geriatric Patients: Effects of Age
Cholesterol: Significance and Regulation
Considering cholesterol and...
Antiepileptic Drugs: Glutamate Antagonists
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists